• News
  • 7 lessons from COVID-19 for pharma companies
News - published on 13 Jul 2021

7 lessons from COVID-19 for pharma companies

There is a long way to go to curb the COVID-19 pandemic. To speed the end of the pandemic, and support a recovery that leaves no-one behind, the Access to Medicine Foundation convened an expert roundtable of pharmaceutical companies and investors. The focus was on practical steps for companies to protect supply chains and scale up production, and ensure health products could continue to reach people.

Explore further

Get in touch

Back to top |